Categories: All posts

Neighbourly Pharmacy stock soars on go-private deal

Shares of Neighbourly Pharmacy (Neighbourly Pharmacy Stock Quote, Chart, News, Analysts, Financials, TSX:NBLY) are leading the TSX today after the company announced a go private deal with Toronto-based Persistence Capital Partners.

Neighbourly says the deal, which is priced at $20.50 and represents a 69 per cent premium to the October 2 closing price of $12.12, is a good one for shareholders. A company Transaction Committee approved the offer unanimously. The company said it expects to hold a special meeting of its shareholders to approve the deal, which it expects to close in late-2023 or early 2024.

“PCP believes that taking Neighbourly private is the best way to unlock its full potential and create long-term value for all stakeholders,” said said PCP managing partner Stuart M. Elman. “As a private company, Neighbourly will have more flexibility and resources to pursue its strategic vision to advance the role that independent pharmacies can play in Canada. We are confident that this proposed transaction will benefit Neighbourly’s customers, patients, employees, and partners, as well as provide a fair and attractive return to its public shareholders.”

Toronto-based Neighbourly owns Canada’s largest network of independent pharmacies.

At press time, shares of NBLY were up 57.8 per cent to $19.12.

Tagged with: nbly
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Will AI kill Shopify?

National Bank Financial analyst Richard Tse said the impact of AI on tech valuations is becoming more company-specific, with names… [Read More]

8 minutes ago

Meta is the best “Magnificent Seven” stock right now, this investor says

ScotiaMcLeod Newman Group advisor and portfolio manager Greg Newman told BNN Bloomberg’s Market Call on April 24 that Meta Platforms … [Read More]

19 hours ago

GLP-1 trade? McKesson is your stock, this investor says

Goodreid Investment Counsel president and CEO Gordon Reid told BNN Bloomberg’s Market Call on April 23 that McKesson (McKesson Stock… [Read More]

19 hours ago

Metatek-Group is a buy, this analyst says

Beacon Securities analyst Russell Stanley initiated coverage of Metatek-Group (Metatek-Group Stock Quote, Chart, News, Analysts, Financials TSX:MTEK) with a “Buy”… [Read More]

20 hours ago

This Canadian penny stock is undervalued, analyst says

Clarus Securities analyst Noel Atkinson said in an April 23 update that AmeriTrust Financial Technologies (AmeriTrust Financial Technologies Stock Quote,… [Read More]

1 day ago

Pot reclassification is not enough to move the needle, analyst says

Haywood analyst Neal Gilmer said the U.S. decision to immediately reclassify state-licensed medical marijuana from Schedule I to Schedule III… [Read More]

2 days ago